Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of acromioclavicular joint osteoarthritis

被引:16
作者
Freitag, Julien [1 ,2 ,3 ]
Wickham, James [1 ]
Shah, Kiran [3 ]
Tenen, Abi [2 ,3 ,4 ,5 ]
机构
[1] Charles Sturt Univ, Sch Biomed Sci, Orange, NSW, Australia
[2] Melbourne Stem Cell Ctr, Box Hill North, Vic, Australia
[3] Magellan Stem Cells, Box Hill North, Vic, Australia
[4] Monash Univ, Monash Univ Sch Primary Hlth Care, Notting Hill, Vic, Australia
[5] Vis Eye Inst, Melbourne, Vic, Australia
关键词
orthopaedics; osteoarthritis; sports and exercise medicine;
D O I
10.1136/bcr-2018-227865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this case report is to evaluate the efficacy of mesenchymal stem cell (MSC) therapy in the treatment of small joint osteoarthritis (OA). Acromio-clavicular (AC) joint OA is an under-diagnosed and yet frequent source of shoulder pain. MSCs have shown evidence of benefit in the treatment of knee OA. This is the first report to describe the use of MSC therapy in OA of the upper limb. A 43-year-old patient presents with painful AC joint OA and undergoes MSC therapy. The patient reported pain and functional improvement as assessed by the Disability of Arm, Shoulder and Hand Score and Numeric Pain Rating Scale. Imaging at 12 months showed structural improvement with reduction in subchondral oedema, synovitis and subchondral cysts. This case is the first to show the benefit of MSC therapy in the treatment of small joint arthropathy and also of the upper limb. Trial registration number: Australian New Zealand Clinical Trials Registry (ACTRN12617000638336).
引用
收藏
页数:5
相关论文
共 35 条
  • [1] Arinzeh Treena Livingston, 2005, Foot Ankle Clin, V10, P651, DOI 10.1016/j.fcl.2005.06.004
  • [2] Mesenchymal stem cells: clinical applications and biological characterization
    Barry, FP
    Murphy, JM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) : 568 - 584
  • [3] Basamania C., 1996, ORTHOP T, V19, P355
  • [4] Blazar PE, 1998, CLIN ORTHOP RELAT R, P114
  • [5] BRUNET ME, 1986, ORTHOPEDICS, V9, P557
  • [6] Why are MSCs therapeutic? New data: new insight
    Caplan, Al
    [J]. JOURNAL OF PATHOLOGY, 2009, 217 (02) : 318 - 324
  • [7] THE MUMFORD PROCEDURE IN ATHLETES - AN OBJECTIVE ANALYSIS OF FUNCTION
    COOK, FF
    TIBONE, JE
    [J]. AMERICAN JOURNAL OF SPORTS MEDICINE, 1988, 16 (02) : 97 - 100
  • [8] Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
    Dominici, M.
    Le Blanc, K.
    Mueller, I.
    Slaper-Cortenbach, I.
    Marini, F. C.
    Krause, D. S.
    Deans, R. J.
    Keating, A.
    Prockop, D. J.
    Horwitz, E. M.
    [J]. CYTOTHERAPY, 2006, 8 (04) : 315 - 317
  • [9] Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
    Dworkin, RH
    Turk, DC
    Farrar, JT
    Haythornthwaite, JA
    Jensen, MP
    Katz, NP
    Kerns, RD
    Stucki, G
    Allen, RR
    Bellamy, N
    Carr, DB
    Chandler, J
    Cowan, P
    Dionne, R
    Galer, BS
    Hertz, S
    Jadad, AR
    Kramer, LD
    Manning, DC
    Martin, S
    McCormick, CG
    McDermott, MP
    McGrath, P
    Quessy, S
    Rappaport, BA
    Robbins, W
    Robinson, JP
    Rothman, M
    Royal, MA
    Simon, L
    Stauffer, JW
    Stein, W
    Tollett, J
    Wernicke, J
    Witter, J
    [J]. PAIN, 2005, 113 (1-2) : 9 - 19
  • [10] Flatow E L, 1995, J Shoulder Elbow Surg, V4, P41